ACTIV trials: Lessons learned in trial design in the setting of an emergent pandemic

By sjmartinez • October 31, 2024

Keshtkar-Jahromi M, Anstrom KJ, Barkauskas C, Brown SM, Daar ES, Fischer W, Gibbs KW, Higgs ES, Hughes MD, Jagannathan P, LaVange L, Lindsell CJ, Nayak SU, Paredes R, Parmar M, Peltan ID, Proschan M, Shotwell MS, Vock DM, Yokum T, Adam SJ. ACTIV trials: Lessons learned in trial design in the setting of an emergent pandemic. J Clin Transl Sci. 2024 Oct 15;8(1):e151. doi: 10.1017/cts.2024.1. PMID: 39478775; PMCID: PMC11523015.

Tags: ACTIV, Clinical Trial, covid-19, design, Infectious Diseases, lessons, Publications

Predicting Oral HIV Pre-Exposure Prophylaxis Efficacy in Cisgender Women Across Pregnancy and Postpartum

Yu Y, Brooks KM, Doncel GF, Best BM, Marzinke MA, Mirochnick M, Anderson PL, Myer L, Celum C, Heffron R, Coleman J, Davey DLJ, Zhang[...]

Transposon Sequencing in Leptospira interrogans

Matsunaga J. Transposon Sequencing in Leptospira interrogans. Methods Mol Biol. 2026;3068:127-137. doi: 10.1007/978-1-0716-5500-9_11. PMID: 42681487.

Staphylococcus aureus Skin and Soft Tissue Infections

Abeydeera-Keshmiri NA, Miller LG. Staphylococcus aureus Skin and Soft Tissue Infections. Infect Dis Clin North Am. 2026 Sep 1:S0891-5520(26)00064-4. doi: 10.1016/j.idc.2026.07.003. Epub ahead of print.[...]